Single Use Downstream Bioprocessing Market Revenue to Cross USD 6.7 Billion by 2035 | Roots Analysis

Published: February 2024

According to a recently published report by Roots Analysis, the growing demand for biologics has surged the requirement for advanced single-use downstream bioprocessing systems, which is anticipated to drive the market during the forecast period.

Single Use Downstream Bioprocessing Market Overview

The global single use downstreaming bioprocessing market is anticipated to grow at a CAGR of 15% from 2023-2035, reaching USD 6.7 billion by 2035.

In the past few years, there has been a significant increase in the demand for biopharmaceutical products to treat diseases. Biologics has shown positive results in the treatment of chronic diseases owing to its high target efficacy and safety profile. To date, over 620 biologics have already been approved by the FDA, and around 8,000 are under clinical trials. The growing pipeline of biologics in clinical trials has demonstrated the popularity of the advanced treatment approach for a variety of diseases. However, conventional manufacturing systems are incapable of meeting the growing demand for biologics due to technical limitations. In order to meet the rising demand for biologics, several industrial players shifted to modernized manufacturing technologies such as single-use downstream bioprocessing systems. These single-use downstream bioprocessing technologies offer several significant benefits, such as a reduction in project lead time (By 8 months), a reduction in CO2 emissions by 35%, and reduced cleaning and sterilization expenditures throughout the processing stage. Moreover, single-use downstream bioprocessing systems are less labor-intensive and reduce the risk of contamination. Owing to the significance offered by the single-use downstream bioprocessing system, several stakeholders are showing keen interest in the development of advanced single-use technologies such as single-use chromatography systems, single-use filtration systems, single-use sampling systems, single-use connectors, and single-use centrifugation systems. The ongoing advancements and rising interest of the industrial players are estimated to grow the single-use downstream bioprocessing market at a substantial rate during the forecast period.

The 222 pages report contain detailed Table of Content on "Single Use Downstreaming Bioprocessing Market by Type of Products, Scale of Operations and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035” here:

Market Drivers

The increasing focus on biopharmaceutical research and development, combined with a growing number of biologics, has fueled the demand for efficient bioprocessing solutions. The growing focus on quality assurance and regulatory compliance also drives the single use downstream bioprocessing market. Single-use bioprocessing systems have been designed to mitigate the risk of cross-contamination between batches to meet regulatory standards, ensuring the purity of the products. Furthermore, single-use downstream processing systems offer the fastest turnaround times and ensure easy scale-down without requiring any modifications. Owing to its significance, pharmaceutical companies have begun to adopt single-use downstream bioprocessing systems for biopharmaceutical product manufacturing, which is anticipated to drive the market.

Market Restraints

The high initial investment in the implementation of single use downstream bioprocessing systems may impact the overall cost of biopharmaceutical products. The utilization of disposable components in single-use systems may contribute to waste generation. Hence, environmental pollution resulting from the waste generated by these systems is a major cause of concern. The lack of technology standardization across different suppliers may pose a challenge for end-users in terms of compatibility and interchangeability.

Growth Factors

Ongoing technical advancements in single-use downstream bioprocessing systems, including automation, sensors, and materials to enhance their efficiency, have contributed to the growth of the market. Single use downstream processing systems have demonstrated the ability to meet urgent manufacturing requirements, contributing to the widespread adoption in pharmaceutical companies. The growing support from regulatory authorities for the use of single-use systems to increase the production of biopharmaceutical products has become a key growth factor.

Single Use Downstream Processing Market Segments

Based on the type of products, the single use downstream bioprocessing market is segmented into single-use chromatography systems, single-use filtration systems, single-use sampling systems, and single-use connectors.

  • Based on the type of products, the single use filtration system will dominate the market and is poised to capture 44% by 2035.
  • Single use sampling systems and single-use chromatography will grow at a higher CAGR of 13% during the forecast period.

Based on scale of operation, the single use downstream bioprocessing market is segmented into preclinical / clinical and commercial.

  • Based on the scale of operation, the commercial operation will dominate the market, holding a significant share of (58%) by 2035.
  • Commercial operations have the potential to grow during the forecast period and are anticipated to grow at a higher CAGR of 22% during the forecast period.

Based on the Regional Insights, the single use downstream bioprocessing market is segmented in North America, Europe, Asia-Pacific, and the Rest of the World.

  • North America is anticipated to hold the maximum share (29%) of the global single use downstream manufacturing market by 2035.
  • In Asia Pacific, the single use downstream bioprocessing market is anticipated to demonstrate lucrative growth and is poised to grow at a CAGR of 20% during the forecast period.

Key Companies Profiled

The single use downstream bioprocessing market report also includes detailed profiles of key players (listed below) that offer aseptic sampling solutions:

  • 3M
  • Agilitech
  • CPC (Colder Products Company)
  • Cytiva Lifesciences
  • Pall Corporation
  • Pneumatic Scale Angelus
  • Thermo Fisher Scientific

You Can Download Free Sample PDF Copy Of This Report At:

Don’t miss out on other interesting titles:

  1. Biologics Contract Manufacturing Market
  2. Molecular Diagnostic Market
  3. Chromatography Instrumentation Market
  4. Single Use Bioreactors Market

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists, and strategic investors for over a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serving our clients in the best possible way.

Contact US
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Email: or


  • We are your partners with no equity

  • We fit in your budget

  • We love what we do

  • Chance to prove ourselves

  • Best in class quality of work

  • Most trusted consulting partner in the industry